B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medicenna Therapeutics Corp. - Common Shares (NQ: MDNA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Nov 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.1510 (5)
Ask (Size) 0.1565 (181)
Prev. Close 0.1570
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dear LUNR Stock Fans, Mark Your Calendars for Jan. 12
Intuitive Machines stock is rising on Monday after the company announced plans for a lunar mission launch in January 2024. 
Via InvestorPlace
Why Is Medicenna Therapeutics (MDNA) Stock Down Today?
Medicenna Therapeutics stock is falling on Monday after the company announced that shares of MDNA will be delisted from the Nasdaq. 
Via InvestorPlace

Performance

More News

Read More
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
The Latest Analyst Ratings for Medicenna Therapeutics
Via Benzinga
Medicenna Therapeutics's Earnings: A Preview
Via Benzinga
Earnings Preview For Medicenna Therapeutics
Via Benzinga
Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Nasdaq Jumps 100 Points; Amazon Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Medicenna Therapeutics Earnings Preview
Via Benzinga
Medicenna's Lead Cancer Program Shows Preliminary Anti-Cancer Activity In Solid Tumor Study
Via Benzinga
Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Could CRISPR Therapeutics Help You Become a Millionaire?
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Earnings Scheduled For November 4, 2022
Via Benzinga
Earnings Outlook For Medicenna Therapeutics
Via Benzinga
Medicenna Therapeutics: Q1 Earnings Insights
Via Benzinga
Recap: Medicenna Therapeutics Q1 Earnings
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Earnings Scheduled For August 15, 2022
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.